Literature DB >> 17219963

Changes of regulatory T cells in Graves' disease.

Hongxiang Wang, Shi Zhao, Xiaoqiong Tang, Jingyuan Li, Ping Zou.   

Abstract

The immune mechanism of Graves' diseases (GD) and the roles of regulator T cells were investigated. In 32 patients with GD (GD group) and 20 healthy volunteers (control group), flow cytometry was used to detect the proportion of CD4+CD25+ cells, MACS to isolate CD4+ CD25+ cells, RT-PCR to assay the expression of FOXP3, and ELISA to test the level of IL-10, respectively. It was found that there was no significant change in the proportion of CD4+CD25+ T cells between GD group and control group (P>0.05), while secretion of IL-10 and expression of FOXP3 in GD group were lower than control group (P<0.01 and P<0.05, respectively). In conclusion, though the proportion of regulatory T cells of peripheral blood lymphocytes in the patients with GD, the functions of them were significantly weakened, which might be a pathogenic factor in GD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17219963     DOI: 10.1007/s11596-006-0515-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  13 in total

Review 1.  The regulatory T cell family: distinct subsets and their interrelations.

Authors:  Helmut Jonuleit; Edgar Schmitt
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

2.  Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.

Authors:  Anette Sundstedt; Emma J O'Neill; Kirsty S Nicolson; David C Wraith
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 3.  Foxp3: a critical regulator of the development and function of regulatory T cells.

Authors:  Shohei Hori; Shimon Sakaguchi
Journal:  Microbes Infect       Date:  2004-07       Impact factor: 2.700

4.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

5.  Use of reverse transcriptase polymerase chain reaction to monitor expression of intronless genes.

Authors:  M Grillo; F L Margolis
Journal:  Biotechniques       Date:  1990-09       Impact factor: 1.993

6.  Changes in Th1/Th2 cytokine balance in Graves' disease.

Authors:  T Kocjan; B Wraber; U Repnik; S Hojker
Journal:  Pflugers Arch       Date:  2000       Impact factor: 3.657

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 9.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

10.  CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.

Authors:  Ciriaco A Piccirillo; John J Letterio; Angela M Thornton; Rebecca S McHugh; Mizuko Mamura; Hidekazu Mizuhara; Ethan M Shevach
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more
  2 in total

1.  Serum miR-146a, miR-155, and miR-210 as potential markers of Graves' disease.

Authors:  Lei Zheng; Chunbo Zhuang; Xiaobei Wang; Liang Ming
Journal:  J Clin Lab Anal       Date:  2017-05-31       Impact factor: 2.352

2.  Impairment of regulatory T-cell function in autoimmune thyroid disease.

Authors:  Abigail B Glick; Alaina Wodzinski; Pingfu Fu; Alan D Levine; David N Wald
Journal:  Thyroid       Date:  2013-07       Impact factor: 6.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.